Related Experiment Video
Updated: Apr 10, 2026

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
Published on: December 29, 2021
The use of cannabinoids as anticancer agents
Guillermo Velasco1, Sonia Hernández-Tiedra1, David Dávila1
1Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University of Madrid, Spain; Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Spain.
Cannabinoids show promise in cancer treatment by reducing tumor growth, inhibiting angiogenesis, and promoting cancer cell death. Research is exploring resistance mechanisms and combination therapies for clinical application.
Area of Science:
- Oncology
- Pharmacology
Background:
- Cannabinoids are recognized for palliative effects on cancer symptoms.
- Recent evidence suggests cannabinoids can inhibit tumor growth in preclinical models.
Purpose of the Study:
- To review the anticancer effects of cannabinoids.
- To explore mechanisms of action, resistance, and future therapeutic strategies.
Main Methods:
- Literature review of preclinical and clinical studies on cannabinoid anticancer effects.
- Analysis of molecular pathways involved in cannabinoid action.
Main Results:
- Cannabinoids activate ER-stress pathways, inducing autophagy-mediated cancer cell death.
- Cannabinoids inhibit tumor angiogenesis and cancer cell migration.
- Mechanisms of resistance and combination therapy strategies are under investigation.
Conclusions:
- Cannabinoids demonstrate significant potential as anticancer agents.
- Further research is paving the way for clinical trials of cannabinoid-based cancer therapies.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Inhibition of Cdk Activity
Drugs that Stabilize Microtubules
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
